sefulness of new liquid enteral nutrition formula in perioperative patients in the field of gastrointestinal surgery.

Not Applicable

Recruiting

• Conditions: Digestive disease

• Registration Number: JPRN-UMIN000049138
• Lead Sponsor: ippon Medical School

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-11-01
• Last Update Posted: 17 October 2023
• Study Completion: 2024-10-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Not provided

Exclusion Criteria

1. Weight loss =>10% (compared to normal weight over the last 6 months). 2. Patients with swallowing dysfunction. 3. Patients with liver dysfunction (Child-Pugh class C). 4. Patients with respiratory dysfunction (arterial blood PaO2<70 torr). 5. Patients with renal impairment (plasma creatinine level >2 mg/dL). 6. Patients with cardiac dysfunction (New York classification>3). 7. Patients who are pregnant. 8. Patients with infectious diseases. 9. Immunocompromised patients. 10. Patients judged to require total parenteral nutrition. 11. Patients who become calorie restricted after hospitalization due to comorbidities, or who may become calorie restricted. 12. Patients judged inappropriate for participation in this research by the principal investigator or co-investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of postoperative infections.